糖耐量减低

tánɡ nài liànɡ jiǎn dī
  • impaired glucose tolerance;IGT
糖耐量减低糖耐量减低
  1. 方法367例超重肥胖者被分成2型糖尿病组、糖耐量减低组、空腹血糖受损组、正常糖耐量组及单纯超重肥胖组,并与66例正常体重者对照。

    Methods 367 subjects with overweight and obesity were divided into 5 groups , including of type 2 diabetes , impaired glucose tolerance , impaired fasting blood glucose , normal glucose tolerance and simple overweight or obesity .

  2. 前列腺素E1对高血压并发糖耐量减低患者血浆P-选择素的影响

    Effects of Lipo-prostaglandin E1 on Plasma GMP-140 in Hypertensive Patients with Impaired Glucose Tolerance

  3. 高敏C反应蛋白与老年糖耐量减低患者不同血糖水平的相关研究

    Relationship between high sensitivity C-reactive protein and different glucose level in the elderly with abnormal glucose metabolism

  4. 无高血压的糖耐量减低患者24h动态血压分析

    Analysis 24-hour ambulatory blood pressure in impaired glucose tolerance patients without hypertension

  5. 目的:研究营养治疗对妊娠期糖尿病(GDM)和糖耐量减低(IGT)的意义。

    Objective : To study the nutritional therapy of GDM and IGT .

  6. 然而,目前对CAMs在糖耐量减低(impairedglucosetolerance,IGT)患者中的表达及其相互关系少有研究,也罕见相关的报道。

    However , relationship between the serum concentrations of CAMs and patients with impaired glucose tolerance ( IGT ) is rarely reported .

  7. 目的探讨妊娠期糖耐量减低(GestationalImpairedGlucoseTolerance,GIGT)并发巨大儿的危险因素与妊娠结局。

    Objective To investigate the risk factors and pregnancy outcomes of gestational impaired glucose tolerance ( GIGT ) in women with macrosomia .

  8. 目的探讨胰岛素抵抗(IR)在糖耐量减低(IGT)大血管并发症中的作用。

    Objective To evaluate the effect of insulin resistance ( IR ) on the macrovascular complications of impaired glucose tolerance ( IGT ) .

  9. 目的确定糖耐量减低(IGT)患者心脏结构和功能的变化。

    Objectives To determine the effect of impaired glucose tolerance ( IGT ) on cardiac structure and function .

  10. OGTT试验诊断糖尿病(DM)、糖耐量减低(IGT)及空腹血糖损害(IFG)的价值。

    Objective To study diagnostic value of OGTT for DM , IGT and IFG when FPG is normal .

  11. 结果GDM产后近期随访诊断为显性糖尿病者23例,糖耐量减低11例,列为产后糖代谢异常组。

    Results 23 of the patients had diabetes and 11 had IGT in the early postpartum follow up .

  12. SF-36量表在糖尿病和糖耐量减低患者生命质量研究中的信度、敏感性和可行性评价

    Evaluation on reliability , sensitivity and feasibility of SF-36 instrument with the quality of life in DM and IGT

  13. 目的探索单纯性肥胖儿童糖耐量减低(IGT)的干预方法。

    Objective To observe the influence of weight - lost therapy on obese children with impaired glucose tolerance ( IGT ), insulin resistance .

  14. 对糖耐量减低(IGT)患者进行干预治疗是预防糖尿病及其并发症的重要环节。

    Precautionary therapy of the patients with impaired glucose tolerance ( IGT ) is important in the prevention of diabetes mellitus and its complications .

  15. 结果按WHO糖尿病(DM)诊断标准,DM患病率为4.23%,糖耐量减低(IGT)患病率为11.94%。

    Results According to the WHO diagnostic standard , the prevalence rates of DM and IGT were 4.23 % and 11.94 % respectively . The prevalence increased apparently with age .

  16. 目的研究糖耐量减低(IGT)者尿中微量蛋白的改变,监测IGT的进展和预防糖尿病(DM)的发生。

    Objective To study the variation of urinary microproteins in patients with impaired glucose tolerance ( IGT ) for preventing the occurence of diabetes mellitus ( DM ) .

  17. 目的观察空腹血糖异常(IFG)、糖耐量减低(IGT)患者血清胰岛素水平的变化。

    Objective To observe the changes of plasma insulin in patient with impaired fasting glucose ( IFG ) or impaired glucose tolerance ( IGT ) .

  18. 目的:在高热量低活动量的现代生活方式影响下,代谢性疾病糖尿病(DM)和糖耐量减低(IGT)的发病率不断攀升。

    Objective : The morbidity of diabetes mellitus ( DM ) and impaired glucose tolerance ( IGT ) is increasing with the effect of modern life style of high calorie and low activity .

  19. 结果DM和糖耐量减低(IGT)患病率为4.16%及5.93%,标化患病率分别为2.96%及4.54%。

    Results The prevalence rates of DM and IGT were 4.16 % and 5.93 % respectively , while the standard prevalence rates of DM and IGT were 2.96 % and 4.54 % respectively .

  20. 应用B型超声显像仪测定了63例非胰岛素依赖型糖尿病(NIDDM)患者、16例糖耐量减低(IGT)患者和22例正常对照者的肾脏体积。

    Kidney volumes ( KV ) were measured by B-ultrasound in 63 non-insulin-dependent diabetes melli-tus ( NIDDM ) , 16 impared glucose tolerance ( IGT ) patients and 22 control subjects .

  21. 提示糖耐量减低和2型搪尿病患者在饮食中可适当降低SFA,增加PUFA,从而改善胰岛素抵抗。

    There are closed relation with SFA , PUFA / SFA and IR . The patients of DM and IGT can reasonably decrease SFA and increase PUFA in dietary to improve insulin sensitivity .

  22. 目的比较空腹血糖受损(IFG)、糖耐量减低(IGT)及IFG+IGT个体的血脂比值,并对其与胰岛素抵抗(IR)的相关性进行分析。

    Objective To compare serum lipoprotein ratios among subjects with impaired fasting glucose ( IFG ), impaired glucose tolerance ( IGT ) and IFG + IGT , and to analyze their association with insulin resistance ( IR ) .

  23. 目的:通过测定P-选择素、假性血友病因子(vonwillebrandfactor,vWF)的含量,探讨不稳定型心绞痛合并糖耐量减低(impairedglucosetolerance,IGT)患者血小板活化状态。

    Objective : To dicuss the state of the high activity of platelet in the patients with unstable angina pectoris ( UAP ) accomplied by impaired glucose tolerance ( IGT ) by measuring the content of P-selectin and von Willebrand factor ( vWF ) .

  24. 162例肥胖者中并2型糖尿病(DM)和糖耐量减低(IGT)者占24.07%,并收缩期和舒张期高血压者分别占32.71%、39.15%。

    In 162 obesity subjects , the incidence of Type 2 diabetes mellitus ( DM ) and impaired glucose tolerance ( IGT ) was 24.07 % , those with systolic hypertension , and diastolic hypertension accounted for 32.71 % and 39.15 % , respectively .

  25. 蚌埠地区糖耐量减低调查资料分析

    An analytic data of impaired glucose tolerance in Bengbu Regional Construction

  26. 糖耐量减低及新诊断糖尿病人的特征比较

    Characteristic Comparison Between the Subjects with IGT and New diagnosed Diabetics

  27. 糖耐量减低患者尿微量白蛋白排泄的探讨

    Investigation into Urinary Microalbumin Excretion in Patients with Impaired Glucose Tolerance

  28. 糖耐量减低常见中医证型的临床特征研究

    The Clinical Features Study on Common TCM Syndromes of Impaired Glucose Tolerance

  29. 糖耐量减低对心脏结构及功能的影响

    Effect of Impaired Glucose Tolerance on Cardiac Structure and Function

  30. 饮食习惯及生活方式与老年人糖耐量减低发病关系的研究

    Association of Food Habit and Life Style with IGT in the Elderly